Pharmaceuticals‘Emerging 8' set to join ‘Big 5' targeted cancer therapy blockbustersDr. Tom Gray 3 Oct 2008
OncologySunitinib is cost effective as a first-line therapy for patients with metastatic renal celMagna Carta 23 Sep 2008
OncologyAvastin the only biologic to show overall survival benefit in some patients with colorectal cancerThe Mail Room 17 Sep 2008
OncologyProstatectomy improves outcome of some men with prostate cancer over watchful waiting 22 Aug 2008
HealthcareResearchers locate, image prostate cancer as it spreads to lymph nodesKim Irwin 14 Jul 2008
